Palbociclib,Letrozole,amivantamab
Pfizer,janssen
['lung', 'nsclc', 'chrysalis-2', 'sclc', 'janssen']
we re presenting new research for patients with #lungcancer from the chrysalis, chrysalis-2 and paloma studies at #asco23. learn more about the potential impact of targeted therapies in patients with egfr-mutated advanced nsclc: 
At Janssen, we never stop working toward a future where disease is a thing of the past. Channel run by Janssen Global Services LLC, NJ, USA.